Melanoma and Pregnancy

References

• Østerlind A, Engholm G, Jensen O M. Trends in cutaneous malignant melanoma in Denmark 1943–1982 by anatomic site. Acta Microbiol Immunol Scand 1988; 96: 953–63
   PubMed Web of Science ®Google Scholar
• Jensen O M, Bolander A M. Trends in malignant melanoma of the skin. World Health State Q 1980; 33: 2–26
   PubMedGoogle Scholar
• Balch C M, Houghton A N, Milton G W, Sober A J, Soong S. Cutaneous melanoma. JB Lippincott Company. 1992; 319–24
   Google Scholar
• Heeman P J, English D R, Holman C D, Armstrong B K. Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981. Cancer 1992; 68: 2079–87
   Google Scholar
• Storm H H, Manders T, Friis S, Bang S. Cancer incidence in Denmark 1989. Danish Cancer Society, Danish Cancer Registry, Copenhagen 1989
   Google Scholar
• Sundhedsstyrelsen. Causes of death in Denmark 1989. Vital-statistik 1991; I: 27, (in Danish)
   Google Scholar
• Derek J W, Strassner H T. Melanoma in pregnancy. Clin Obst Gynecol 1990; 33: 782–791
   PubMedGoogle Scholar
• Colborn D S, Nathanson L, Belilos E. Pregnancy and malignant melanoma. Semin Oncol 1989; 16: 377–87
   PubMedGoogle Scholar
• Matthiasen L, Berg G. Malignant melanoma, the most common cancer type, first appearing during pregnancy. Läkartid-ningen 1989; 86: 2845–8, (in Swedish)
   PubMedGoogle Scholar
• Ries L G, Pollack E S, Young J L, Jr. Cancer patient survival: Surveillance, epidemiology and end results program, 1973–79. J Natl Cancer Inst 1983; 70: 693–707
   PubMed Web of Science ®Google Scholar
• Thörn M, Adam H-O, Ringborg U, Bergström R, Krusemo U-B. Long-term survival in malignant melanoma with special reference to age and sex as prognostic factors. J Natl Cancer Inst 1987; 79: 969–74
   PubMedGoogle Scholar
• Shaw H M, Milton G W, Farago G, McCarthy W H. Endocrine influences on survival from malignant melanoma. Cancer 1978; 42: 669–77
   PubMed Web of Science ®Google Scholar
• Reintgen D S, McCarty K S, Vollmer R, Cox E, Seigler H F. Malignant melanoma and pregnancy. Cancer 1985; 55: 1340–4
   PubMed Web of Science ®Google Scholar
• Danforth D N, Russel N, McBride C M. Hormonal status of patients with primary malignant melanoma: A review of 313 cases. South Med J 1982; 75: 6
   PubMedGoogle Scholar
• Rampen F. Malignant melanoma: Sex differences in survival after evidence of distant metastasis. Br J Cancer 1980; 42: 52
   PubMed Web of Science ®Google Scholar
• Shiu M H, Schottenfeld D, MacLean B, Fortner J G. Adverse effect of pregnancy on melanoma. Cancer 1976; 37: 181–7
   PubMed Web of Science ®Google Scholar
• Houghton A N, Flannery J, Viola M V. Malignant melanoma of the skin occurring during pregnancy. Cancer 1981; 48: 407–10
   PubMed Web of Science ®Google Scholar
• Yeu-Tsu N ML. Better prognosis of many cancers in female: A phenomenon not explained by study of steroid receptors. J Surg Oncol 1984; 25: 255–62
   PubMedGoogle Scholar
• Slingluff C L, Reintgen D S, Vollmer R T, Seigler H F. Malignant melanoma arising during pregnancy. Ann Surg 1990; 211: 552–9
   PubMedGoogle Scholar
• Rose C, Pedersen L, Mouridsen H T. Endocrine treatment with anti-estrogen, anti-androgen, or progesterone of advanced malignant melanoma. Eur J Cancer Clin Oncl 1985; 21: 1171–4
   PubMedGoogle Scholar
• Zanetti R, Franceschi S, Rosso S, Bidoli E, Colonna S. Cutaneous malignant melanoma in females: The role of hormonal and reproductive factors. Int J Epidemiol 1990; 19: 522–6
   PubMed Web of Science ®Google Scholar
• Østerlind A. Malignant melanoma in Denmark. Occurrence and risk factors. Acta Oncol 1990; 29: 833–54
   PubMed Web of Science ®Google Scholar
• Franceschi S, Baron A E, La Vecchia C. The influence of female hormones on malignant melanoma. Tumori 1990; 76: 439–49
   PubMedGoogle Scholar
• Gallagher R P, Elmood J M, Hill G B, Coldman A J, Threlfall W J, Spinelli J J. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study. Br J Cancer 1985; 52: 901–7
   PubMed Web of Science ®Google Scholar
• Holly E A, Weiss N S, Liff J M. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. JNCI 1983; 70: 827–31
   PubMedGoogle Scholar
• Holman C DJ, Armstrong B K, Heenan P J. Cutaneous malignant melanoma in women: Exogenous sex hormones and reproductive factors. Br J Cancer 1984; 50: 673–80
   PubMed Web of Science ®Google Scholar
• Green A, Bain C. Hormonal factors and melanoma in women. J Aust 1985; 142: 446–8
   PubMed Web of Science ®Google Scholar
• Bork K, Bräuninger W. Endokrine Beeinflussung des malig-nen Melanoms. Dtsch Med Wochensch 1981; 106: 1329–33
   PubMedGoogle Scholar
• Holly E A, Aston D A, Ahn D K, Kristiansen J J, Char D H. Uveal melanoma, hormonal and reproductive factors in women. Cancer Res 1991; 51: 1370–2
   PubMed Web of Science ®Google Scholar
• Wyshak G, Frisch R E, Albright N L, Albright T E, Schiff I. Reproductive factors and melanoma of the skin among women. Int J Dermatol 1989; 28: 527–30
   PubMedGoogle Scholar
• Hersey P, Morgan G, Stone D E, McCarthy W H, Milton G W. Previous pregnancy as protective factor against death from melanoma. Lancet 1977; 1: 451–2
   PubMedGoogle Scholar
• Elwood J M, Coldman A J. Previous pregnancy and melanoma prognosis. Lancet 1978; 2: 1000
   PubMedGoogle Scholar
• Lederman J S, Sober A J. Effect of prior pregnancy on melanoma survival. Arch Dermatol 1985; 121: 716
   PubMedGoogle Scholar
• Trapeznikov N N, Khasanov S R, Yavorsky W. Skin melanoma and pregnancy. Voproxy Onkologii 1987; 33: 40–6, and International Melanoma Congress II, Venice 1989
   PubMedGoogle Scholar
• MacKie R M, Bufalino R, Morabito A, Southerland C, Cascinelli N. Lack of effect of pregnancy on outcome of melanoma. Lancet 1991; 337: 653–5
   PubMedGoogle Scholar
• Sutherland C M, Loutfi A, Mather F J, Carter R D, Krementz E T. Effect of pregnancy upon malignant melanoma. Surg Gynecol Obstet 1983; 157: 443–6
   PubMedGoogle Scholar
• Wong J H, Sterns E E, Kopald K H, Nizze J A, Morton D L. Prognostic significance of pregnancy in stage I melanoma. Arch Surg 1989; 124: 1227–31
   PubMedGoogle Scholar
• George P A, Fortner J G, Pack G T. Melanoma with pregnancy. Cancer 1960; 13: 854–9
   PubMedGoogle Scholar
• Bork K, Brauninger W, Czarnetzki B M, et al. Schwanger-schaft nach malignem Melanom. Dtsch Med Wochenschr 1985; 110: 1323–7
   PubMedGoogle Scholar
• Rampen F HJ. Comments on steroid hormon receptors in melanoma. Arch Dermatol Res 1983; 275: 208–9
   PubMedGoogle Scholar
• Seddon J M, MacLaughlin D T, Albert D M, Gragoudas E S, Ference M. Uveal melanomas presenting during pregnancy and investigation of oestrogen receptors in melamomas. Br J Ophtalmol 1982; 66: 695–704
   PubMed Web of Science ®Google Scholar
• Green A. Oral contraceptives and skin neoplasia. Contraception 1991; 43: 653–66
   PubMedGoogle Scholar
• Howes W. Removal of testes in treatment of melanoma. JAMA 1943; 123: 304
   Google Scholar
• Ayala A R, Saad A, Vazquez X, Ramirez-Wiella G, Perches R D. Human chorionic gonadotropin immunoreactivity in serum of patients with malignant neoplasms. Am J. Reprod Immunol 1983; 3: 149–51
   Google Scholar
• Russo I H, Koszalka M, Russo J. Comparative strudy of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer 1991; 64: 481–4
   PubMed Web of Science ®Google Scholar
• Jones P C, Sze L L, Liu P Y, Morton D L, Irie R F. Prolonged survival for melanoma patients with elevated igm antibody to oncofetal antigen. JNCI 1981; 66: 249–54
   PubMed Web of Science ®Google Scholar
• Cochran A J, Todd G, Hart D M, Morrison L JA, Mackie R M. Reaction of the leucocytes of melanoma patients and control donors, including pregnant women, with melanoma- and fetus-derived materials. Cancer Immunol Immunother 1982; 14: 78–81
   PubMedGoogle Scholar
• Donegan W L. Breast cancer and pregnancy. Obstet Gynecol 1976; 50: 244–52
   Google Scholar